CJC-1295 No DAC + Ipamorelin 10mg

$89.99

CJC-1295 No DAC + Ipamorelin 10mg Canada from Vantage Labs. A dual-peptide blend for research into GHRH, ghrelin-receptor secretagogue and growth-hormone-axis signaling. Research use only; not for human or veterinary use.

CJC-1295 No DAC + Ipamorelin 10mg Canada from Vantage Labs is supplied exclusively for controlled laboratory research. CJC-1295 No DAC is a growth-hormone-releasing-hormone analogue, while ipamorelin is a growth-hormone secretagogue that acts through the ghrelin receptor pathway. The combination is studied as a research model for two distinct inputs into growth-hormone-axis signaling. The 10mg presentation is relevant to laboratories examining receptor signaling, secretagogue biology, pulsatile growth-hormone dynamics, and downstream IGF-1-related pathways. Because the two components act through different receptor systems, the blend is especially useful as a topic for mechanistic comparison rather than as a basis for assuming a specific human outcome.

What researchers study with CJC-1295 No DAC + Ipamorelin 10mg

The research intent behind this product is mechanism-first: researchers are generally looking for the compound identity, pathway relevance, experimental context, and the limits of the published evidence. Related searches such as CJC-1295 No DAC Canada, Ipamorelin Canada, CJC Ipamorelin blend research are therefore addressed naturally rather than repeated as keyword blocks.

Primary research areas

  • GHRH-receptor and growth-hormone secretagogue receptor signaling.
  • Experimental growth-hormone pulsatility and endocrine feedback models.
  • Downstream IGF-1 and metabolic signaling research.
  • Comparative studies of dual-pathway peptide stimulation.

Evidence and research limitations

Research on growth-hormone-axis compounds spans preclinical and clinical settings, but a research blend should not be presented as an approved treatment or as evidence of a predictable performance outcome. Exact composition, identity, and study design must be considered when interpreting results. Vantage Labs intentionally separates published research context from product marketing so that early-stage evidence is not turned into a promised human result.

Vantage Labs Canada research standard

This page is designed for Canadian research sourcing intent with clear compound naming, exact product strength, concise mechanism context, and research-use boundaries. Certificate of Analysis documentation is available upon request where applicable. Batch-specific identity, purity, testing, storage, and other quality statements should always be confirmed from the applicable documentation rather than assumed from general product copy.

Research use only

For research purposes only. Not for human or veterinary use. Not intended for human or animal consumption. No personalized dosing, administration, injection, cycle, reconstitution, diagnosis, treatment, or medical-use guidance is provided or implied.

Size

10mg